ArticleThe Journal of experimental medicine2026

Targeting Mettl8-Tcf1 axis promotes CD8+ TPEX differentiation and antitumor immunity.

Jiaxi Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.